Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) EBITDA

Insight Molecular Diagnostics Inc. (IMDX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$10.74M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$3.78M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$22.87M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$10.46M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$10.74M(m)(m)(m)-4492.47%$779.00K*-$9.27M*(m)$4.49M(m)$0.00
2026-03-31Reported-$3.78M(m)(m)(m)-11818.75%$613.00K-$7.64M(m)$4.95M(m)$0.00
2025-12-31Reported-$22.87M(m)(m)(m)-2008.08%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$10.46M(m)(m)(m)-4024.62%$1.05M*-$4.63M*(m)$3.88M(m)$0.00
2025-06-30Reported-$9.28M(m)(m)(m)-1792.08%$349.00K*-$6.17M*(m)$3.27M(m)$0.00
2025-03-31Reported-$6.31M(m)(m)(m)-295.04%$307.00K-$5.84M(m)$2.92M(m)$0.00
2024-12-31Reported-$33.06M(m)(m)(m)-2225.03%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$13.18M(m)(m)(m)-11456.52%$87.00K*-$5.53M*(m)$2.82M(m)$0.00
2024-06-30Reported-$4.31M(m)(m)(m)-4140.38%$191.00K*-$5.98M*(m)$2.45M(m)$0.00
2024-03-31Reported-$8.93M(m)(m)(m)-5075.00%$24.00K-$3.83M(m)$2.31M(m)$0.00
2023-09-30Reported(m)-$6.51M(m)$429.00K(m)(m)-$3.77M*(m)$2.19M(m)(m)
2023-06-30Reported(m)-$8.29M(m)$463.00K(m)(m)-$6.83M*(m)$2.44M(m)(m)
2023-03-31Reported(m)$5.85M(m)$297.00K(m)(m)-$8.30M(m)$2.13M(m)(m)
2022-09-30Reported(m)-$1.71M(m)$67.00K(m)$859.00K*-$11.40M*(m)$1.47M(m)(m)
2022-06-30Reported(m)-$1.63M(m)$237.00K(m)$1.12M*-$11.25M*(m)$2.44M(m)(m)
2022-03-31Reported(m)-$3.02M(m)$380.00K(m)$1.56M-$13.28M(m)$2.01M(m)(m)
2021-12-31Reported(m)-$35.68M(m)$3.59M(m)(m)(m)(m)$4.59M(m)-$97.00K
2021-09-30Reported(m)-$13.60M(m)$984.00K(m)$394.00K*-$10.98M*(m)$3.14M(m)$0.00*
2021-06-30Reported(m)-$13.57M(m)$2.03M(m)$610.00K*-$8.06M*(m)$2.54M(m)-$1.79M
2021-03-31Reported-$11.12M(m)(m)(m)-989.41%$842.00K-$9.84M(m)$3.36M(m)-$7.56M
2020-12-31Reported(m)-$6.27M(m)$503.00K(m)(m)(m)(m)$1.80M(m)$159.00K
2020-09-30Reported(m)-$6.24M(m)$555.00K(m)$526.00K*-$6.00M*(m)$2.62M(m)$0.00*
2020-06-30Reported(m)-$8.77M(m)$143.00K(m)$491.00K*-$6.96M*(m)$3.23M(m)-$2.19M*
2020-03-31Reported-$8.37M(m)(m)(m)-52318.75%$44.00K-$6.87M(m)$2.16M(m)$1.09M
2019-09-30Reported(m)-$5.26M(m)(m)(m)$0.00*-$4.85M*(m)$1.63M(m)(m)
2019-06-30Reported(m)-$5.46M(m)(m)(m)$11.00K*-$2.84M*(m)$1.51M(m)(m)
2019-03-31Reported(m)-$4.00M(m)(m)(m)$7.00K-$6.72M(m)$1.34M(m)(m)
2018-09-30Reported(m)-$3.02M(m)(m)(m)$9.00K*-$2.48M*(m)$1.53M(m)(m)
2018-06-30Reported(m)-$4.23M(m)(m)(m)$17.00K*-$3.96M*(m)$2.32M(m)(m)
2018-03-31Reported(m)-$3.91M(m)(m)(m)$5.00K-$2.75M(m)$1.46M(m)(m)
2017-09-30Reported(m)-$6.83M(m)(m)(m)$30.00K*-$3.47M*(m)$1.84M(m)(m)
2017-06-30Reported(m)-$3.59M(m)(m)(m)$39.00K*-$3.28M*(m)$2.00M(m)(m)
2017-03-31Reported(m)-$4.53M(m)(m)(m)$16.00K-$3.29M(m)$1.83M(m)(m)
2016-09-30Reported(m)-$2.58M(m)(m)(m)$9.00K*-$1.03M*(m)$1.36M(m)(m)
2016-06-30Reported(m)-$2.53M(m)(m)(m)-$5.00K*(m)(m)$1.20M(m)(m)
2016-03-31Reported(m)-$2.93M(m)(m)(m)$15.00K(m)(m)$1.69M(m)(m)
2015-09-30Reported(m)-$2.41M(m)(m)(m)$0.00*(m)(m)$1.09M(m)(m)
2015-06-30Reported(m)-$1.41M(m)(m)(m)$0.00*(m)(m)$886.00K(m)(m)
2015-03-31Reported(m)-$1.37M(m)(m)(m)$11.00K(m)(m)$1.12M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$48.93M(m)(m)(m)-1206.58%$3.19M-$22.18M(m)$15.90M(m)$0.00
2024-12-31Reported-$59.48M(m)(m)(m)-3161.99%$516.00K-$20.69M(m)$9.84M(m)$0.00
2023-12-31Reported-$23.46M(m)(m)(m)-1560.61%$281.00K-$23.32M(m)$9.29M(m)$0.00
2022-12-31Reported(m)-$18.00M(m)$958.00K(m)$4.34M-$45.57M(m)$7.30M(m)(m)
2022-09-30Rolling(m)-$42.03M*(m)$4.27M*(m)(m)(m)(m)$10.51M*(m)(m)
2022-06-30Rolling(m)-$53.93M*(m)$5.19M*(m)(m)(m)(m)$12.18M*(m)(m)
2022-03-31Rolling(m)-$65.87M*(m)$6.98M*(m)(m)(m)(m)$12.28M*(m)(m)
2021-12-31Reported(m)-$53.73M(m)$2.20M(m)$2.25M-$35.94M(m)$5.04M(m)-$9.26M
2021-12-31Rolling(m)-$74.21M*(m)$7.73M*(m)(m)(m)(m)$13.63M*(m)-$9.46M*
2021-09-30Rolling(m)-$44.80M*(m)$4.64M*(m)(m)(m)(m)$10.84M*(m)-$9.20M*
2021-06-30Rolling(m)-$37.44M*(m)$4.21M*(m)(m)(m)(m)$10.31M*(m)-$9.20M*
2021-03-31Rolling(m)-$32.64M*(m)$2.33M*(m)(m)(m)(m)$11.00M*(m)-$9.60M*
2020-12-31Reported(m)-$29.71M(m)$1.22M(m)$1.23M-$25.98M(m)$9.80M(m)-$1.25M
2020-12-31Rolling(m)-$29.71M*(m)$1.22M*(m)(m)(m)(m)$9.80M*(m)-$936.00K*
2019-12-31Reported(m)-$22.24M(m)(m)(m)$918.00K-$19.71M(m)$6.79M(m)(m)
2018-12-31Reported(m)-$15.20M(m)(m)(m)$31.00K-$11.65M(m)$6.51M(m)(m)
2017-12-31Reported(m)-$18.85M(m)(m)(m)$91.00K-$13.38M(m)$7.17M(m)(m)
2016-12-31Reported(m)-$11.14M(m)(m)(m)$106.00K-$7.52M(m)$5.68M(m)(m)
2015-12-31Reported(m)-$8.72M(m)(m)(m)$500.00K-$4.23M(m)$4.53M(m)(m)
2014-12-31Reported(m)-$4.97M(m)(m)(m)$9.00K(m)(m)$3.96M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92